Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Immunoglobulin g (human)
Drug ID BADD_D01145
Description Intravenous immunoglobulin (IVIg) is a mixture of IgG1 and other antibodies derived from healthy human plasma via Cohn fractionation. The purification process includes cold alcohol fractionation, polyethylene glycol precipitation, and ion exchange chromatography. IVIg contains the same distribution of IgG antibody subclasses as is found in the general human population. IgG subclasses are fully represented in the following proportions: 70.3% IgG1, 24.7% IgG2, 3.1% IgG3, and 1.9% IgG4. IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders.
Indications and Usage IVIg is used in the treatment of immunodeficiencies, as well as autoimmune and inflammatory disorders. These indications includes idiopathic thrombocytopenic purpura, Kawasaki disease, hypogammaglobulinemia, B cell chronic lymphocytic leukemia, bone marrow transplant complications, Guillain-Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP), multiple sclerosis, rheumatoid arthritis, myesthenia gravis, Wiskott–Aldrich syndrome and inflammatory skin diseases.
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB00028
KEGG ID Not Available
MeSH ID D007074
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code 44206-451; 44206-457; 69800-0250; 64208-8234; 44206-438; 64208-8235; 44206-454; 44206-452; 44206-456; 44206-436; 44206-437; 44206-439; 44206-455; 44206-458
UNII Not Available
Synonyms Immunoglobulin G | IgG | IgG Antibody | Antibody, IgG | Gamma Globulin, 7S | 7S Gamma Globulin | IgG2A | IgG2B | Polyglobin | Allerglobuline | IgG(T) | Immunoglobulin GT | GT, Immunoglobulin | IgG1 | IgG4 | IgG2 | IgG3
Chemical Information
Molecular Formula Not Available
CAS Registry Number 308067-58-5
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Headache17.14.01.001--
Heart rate increased13.14.04.002---
Hepatic function abnormal09.01.02.001---
Hyperhidrosis08.01.03.028; 23.02.03.004--
Hypersensitivity10.01.03.003--
Hypertension24.08.02.001--
Hypotension24.06.03.002--
Hypoxia22.02.02.003--
Insomnia17.15.03.002; 19.02.01.002--
Leukopenia01.02.02.001---
Loss of consciousness17.02.04.004---
Meningitis aseptic11.01.03.002; 17.06.03.002---
Migraine17.14.02.001; 24.03.05.003---
Myocardial infarction02.02.02.007; 24.04.04.009--
Nausea07.01.07.001--
Nephrotic syndrome20.05.01.002--
Oedema08.01.07.006; 14.05.06.010---
Oxygen saturation decreased13.02.01.004---
Pain08.01.08.004--
Pain in extremity15.03.04.010--
Pancytopenia01.03.03.003---
Phlebitis12.02.01.002; 24.12.03.004--
Pruritus23.03.12.001--
Pulmonary embolism22.06.02.001; 24.01.06.001---
Pulmonary oedema02.05.02.003; 22.01.03.003--
Pyrexia08.05.02.003--
Rash23.03.13.001---
Renal failure20.01.03.005---
Seizure17.12.03.001--
Skin irritation23.03.04.009---
The 2th Page    First    Pre   2 3    Next   Last    Total 3 Pages